Treatment Information

Back

Liver Cancer treatment details. Biologic therapy.

Yonsei University College of Medicine, Seoul, Korea.

Survival: monthsCountry:Korea
Toxiciy Grade:4City/State/Province:Seoul
Treatments:Biologic therapyHospital:Yonsei University College of Medicine
Drugs:Journal:Link
Date:Oct 2013

Description:

Patients:
This study involved 226 advanced hepatocellular cancer patients with a median age of 57 years, 83.2% of whom were male.

Treatment:
Patients were treated with the biologic therapy agent sorafenib, which is a tyrosine kinase inhibitor that interferes with tumor growth.

Toxicities:
The most severe toxicities were of grade 4 and included grade 2-4 hand-foot syndrome (skin reaction), diarrhea, and abdominal pain.

Results:
The median overall survival was 5.5 months.

Correspondence: Dr. Kwang-Hyub Han; email: [email protected]



Back